| Bivariate analysis | Multivariable analysisa | ||
---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | |
RRI (0.01 unit step) | 1.13 (1.04–1.23) | 0.005 | 1.22b (1.07–1.41) | 0.004 |
Age | 0.97 (0.91–1.03) | 0.296 |  |  |
BMI | 1.11 (0.99–1.23) | 0.067 | 1.23 (1.02–1.48) | 0.031 |
Risk factors for AKI | ||||
 Hypertension | 1.35 (0.44–4.13) | 0.601 |  |  |
 Diabetes | 1.28 (0.32–5.10) | 0.729 |  |  |
 Chronic lung disease | 0.63 (0.16–2.50) | 0.513 |  |  |
 Chronic kidney diseasec | 7.50 (0.81–70) | 0.076 | 175 (3.72–8281) | 0.009 |
 No risk factord | 1.60 (0.48–5.37) | 0.447 |  |  |
Data at RRI measurement | ||||
 Mechanical ventilation | 6.79 (1.32–35) | 0.022 | f |  |
 Prone position | 0.97 (0.23–4.12) | 0.965 |  |  |
 Vasopressors | 4.11 (1.27–13) | 0.019 | 27 (2.68–268) | 0.005 |
Treatment in ICUe | ||||
 Anti-inflammatory drugs | ||||
  Corticosteroids | 0.76 (0.22–2.61) | 0.666 |  |  |
 Anticoagulation drugs | ||||
  Antiplatelets | 0.36 (0.11–1.19) | 0.094 | 0.18 (0.03–1.17) | 0.073 |
  Episode of thrombolysis | 4.05 (0.39–42) | 0.241 |  |  |